These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 12465059

  • 1. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
    Hagell P, Nordling S, Reimer J, Grabowski M, Persson U.
    Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
    [Abstract] [Full Text] [Related]

  • 2. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
    Wang G, Cheng Q, Zheng R, Tan YY, Sun XK, Zhou HY, Ye XL, Wang Y, Wang Z, Sun BM, Chen SD.
    Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
    [Abstract] [Full Text] [Related]

  • 3. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z, Qu B, Wu XT, Yang TH, Zhang Q, Zhou D.
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [Abstract] [Full Text] [Related]

  • 4. Drug and treatment costs in Parkinson's disease patients in Sweden.
    Lökk J, Borg S, Svensson J, Persson U, Ljunggren G.
    Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
    [Abstract] [Full Text] [Related]

  • 5. Costs of Parkinson's disease in eastern Europe: a Czech cohort study.
    Winter Y, von Campenhausen S, Brozova H, Skoupa J, Reese JP, Bötzel K, Eggert K, Oertel WH, Dodel R, Ruzicka E.
    Parkinsonism Relat Disord; 2010 Jan; 16(1):51-6. PubMed ID: 19665915
    [Abstract] [Full Text] [Related]

  • 6. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O, Alvegård T, Conradi N, Lenhoff S, Mellqvist UH, Persson U, Löthgren M.
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [Abstract] [Full Text] [Related]

  • 7. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
    Cordato DJ, Schwartz R, Abbott E, Saunders R, Morfis L.
    J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
    [Abstract] [Full Text] [Related]

  • 8. Trends in resource utilization for Parkinson's disease in Germany.
    Winter Y, Balzer-Geldsetzer M, von Campenhausen S, Spottke A, Eggert K, Oertel WH, Dodel R.
    J Neurol Sci; 2010 Jul 15; 294(1-2):18-22. PubMed ID: 20493500
    [Abstract] [Full Text] [Related]

  • 9. The economic consequences of asthma among adults in Sweden.
    Jansson SA, Rönmark E, Forsberg B, Löfgren C, Lindberg A, Lundbäck B.
    Respir Med; 2007 Nov 15; 101(11):2263-70. PubMed ID: 17689234
    [Abstract] [Full Text] [Related]

  • 10. Burden of illness in Parkinson's disease.
    Huse DM, Schulman K, Orsini L, Castelli-Haley J, Kennedy S, Lenhart G.
    Mov Disord; 2005 Nov 15; 20(11):1449-54. PubMed ID: 16007641
    [Abstract] [Full Text] [Related]

  • 11. Resource utilization and cost of rheumatic fever.
    Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilário MO.
    J Rheumatol; 2001 Jun 15; 28(6):1394-7. PubMed ID: 11409136
    [Abstract] [Full Text] [Related]

  • 12. Cost of radiotherapy in Sweden.
    Acta Oncol; 1996 Jun 15; 35 Suppl 6():57-71. PubMed ID: 9154086
    [Abstract] [Full Text] [Related]

  • 13. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P.
    Int J Clin Pract; 2008 May 15; 62(5):708-16. PubMed ID: 18355236
    [Abstract] [Full Text] [Related]

  • 14. Economic burden of illness imposed by severe sepsis in Austria.
    Schmid A, Schneider H, Adlof A, Smolle KH, Edelmann G, Sporn P, Frass M, Sumann G, Koller W, Schobersberger W.
    Wien Klin Wochenschr; 2002 Aug 30; 114(15-16):697-701. PubMed ID: 12602114
    [Abstract] [Full Text] [Related]

  • 15. Resource use and costs associated with different states of breast cancer.
    Lidgren M, Wilking N, Jönsson B, Rehnberg C.
    Int J Technol Assess Health Care; 2007 Aug 30; 23(2):223-31. PubMed ID: 17493308
    [Abstract] [Full Text] [Related]

  • 16. Costs of illness and care in Parkinson's disease: an evaluation in six countries.
    von Campenhausen S, Winter Y, Rodrigues e Silva A, Sampaio C, Ruzicka E, Barone P, Poewe W, Guekht A, Mateus C, Pfeiffer KP, Berger K, Skoupa J, Bötzel K, Geiger-Gritsch S, Siebert U, Balzer-Geldsetzer M, Oertel WH, Dodel R, Reese JP.
    Eur Neuropsychopharmacol; 2011 Feb 30; 21(2):180-91. PubMed ID: 20888737
    [Abstract] [Full Text] [Related]

  • 17. Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients.
    Stålhammar J, Stern L, Linder R, Sherman S, Parikh R, Ariely R, Wikström G.
    J Med Econ; 2012 Feb 30; 15(5):938-46. PubMed ID: 22510016
    [Abstract] [Full Text] [Related]

  • 18. The societal cost of schizophrenia in Sweden.
    Ekman M, Granstrom O, Omerov S, Jacob J, Landen M.
    J Ment Health Policy Econ; 2013 Mar 30; 16(1):13-25. PubMed ID: 23676412
    [Abstract] [Full Text] [Related]

  • 19. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
    Cubo E, Martínez Martin P, González M, Frades B, miembros del grupo ELEP.
    Neurologia; 2009 Mar 30; 24(1):15-23. PubMed ID: 19003550
    [Abstract] [Full Text] [Related]

  • 20. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K, Danchenko N, Gondek K, Schwartz B, Thompson D.
    Urol Oncol; 2007 Mar 30; 25(5):368-75. PubMed ID: 17826652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.